Iterum Therapeutics plc

NasdaqCM:ITRM Stock Report

Mkt Cap: US$17.9m

Iterum Therapeutics Dividend

Dividend criteria checks 0/6

Iterum Therapeutics plc does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareUS$0
Earnings per share-US$3.56
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

Aug 19
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

Iterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.03

Aug 12

Iterum jumps 64% as FDA agrees to Phase 3 trial for UTI candidate

Jul 11

Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

May 06
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

Jan 12
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?

Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?

Sep 25
Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?

Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy

Jul 05

It's Unlikely That The CEO Of Iterum Therapeutics plc (NASDAQ:ITRM) Will See A Huge Pay Rise This Year

Jun 11
It's Unlikely That The CEO Of Iterum Therapeutics plc (NASDAQ:ITRM) Will See A Huge Pay Rise This Year

Is Iterum Therapeutics (NASDAQ:ITRM) Using Debt Sensibly?

May 20
Is Iterum Therapeutics (NASDAQ:ITRM) Using Debt Sensibly?

Have Insiders Been Selling Iterum Therapeutics plc (NASDAQ:ITRM) Shares?

Feb 04
Have Insiders Been Selling Iterum Therapeutics plc (NASDAQ:ITRM) Shares?

This Insider Has Just Sold Shares In Iterum Therapeutics plc (NASDAQ:ITRM)

Feb 04
This Insider Has Just Sold Shares In Iterum Therapeutics plc (NASDAQ:ITRM)

Iterum Therapeutics shares slide 13% on raising $10M

Feb 03

Iterum Therapeutics rises 39% on RA Capital stake disclosure

Dec 03

Iterum Therapeutics files US application for sulopenem in urinary tract infections

Nov 30

Iterum Therapeutics EPS beats by $0.45

Nov 16

Dividend Yield vs Market

Iterum Therapeutics Dividend Yield vs Market
How does ITRM dividend yield compare to the market?
SegmentDividend Yield
Company (ITRM)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.6%
Analyst forecast in 3 Years (ITRM)n/a

Notable Dividend: Unable to evaluate ITRM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ITRM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

How stable has Iterum Therapeutics's dividend per share been in the past?
MonthDividend Per Share (annual)Avg. Yield (%)

Stable Dividend: Insufficient data to determine if ITRM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ITRM's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ITRM has not reported any payouts.


Discover strong dividend paying companies